Language
English
Publication Date
7-26-2022
Journal
World Journal of Cardiology
DOI
10.4330/wjc.v14.i7.392
PMID
36161057
PMCID
PMC9350602
PubMedCentral® Posted Date
7-26-2022
PubMedCentral® Full Text Version
Post-print
Abstract
Coronavirus disease 2019 (COVID-19) is primarily an infection of the respiratory tract, but it can have multisystem manifestations. Cardiac complications of COVID-19 can range from acute myocardial injury, cardiac arrhythmias, or heart failure, amongst others. Heart failure (HF) in COVID-19 can be a de novo process or due to worsening of pre-existing cardiovascular ailment. HF in a patient with COVID-19 not only poses challenges in clinical presentation and management of COVID-19 but also affect prognosis of the patient. This article aims to succinctly revisit the implications of this pandemic regarding pre-existing HF or new-onset HF based on prevailing data. It also focuses on the management and special recommendations from prior studies and guidelines.
Keywords
COVID-19, Coronavirus, Cardiomyopathy, Heart failure, Cardiomyopathy
Published Open-Access
yes
Recommended Citation
Sharma, Munish; Jagirdhar, Gowthami Sai Kogilathota; Guntupalli, Kalpalatha K; et al., "Heart Failure in General and Cardiac Transplant Patients With COVID-19" (2022). Faculty and Staff Publications. 874.
https://digitalcommons.library.tmc.edu/baylor_docs/874
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Cardiology Commons, Cardiovascular Diseases Commons, Community Health and Preventive Medicine Commons, COVID-19 Commons, Health Services Administration Commons, Medical Sciences Commons, Respiratory Tract Diseases Commons